Replication/Assembly Defective Avian Flavivirus With Internal Deletions in the Capsid Can Be Used as an Approach for Living Attenuated Vaccine
Yu He,Xiaoli Wang,Jiaqi Guo,Li Mao,Senzhao Zhang,Tao Hu,Mingshu Wang,Renyong Jia,Dekang Zhu,Mafeng Liu,Xinxin Zhao,Qiao Yang,Ying Wu,Shaqiu Zhang,Juan Huang,Sai Mao,Xumin Ou,Qun Gao,Di Sun,Yunya Liu,Ling Zhang,Yanling Yu,Anchun Cheng,Shun Chen
DOI: https://doi.org/10.3389/fimmu.2021.694959
IF: 7.3
2021-01-01
Frontiers in Immunology
Abstract:Avian Tembusu virus (TMUV) is a novel flavivirus causing severe egg drop and fatal encephalitis in avian in Asia. In the present study, we screened the structural and functional requirements of TMUV capsid protein (CP) for viral morphogenesis using reverse genetics methods in combination with replicon packaging assays. TMUV-CP showed dramatic functional and structural flexibility, and even though 44 residues were removed from the N-terminus, it was still capable of packaging replicon RNA; in addition, 33 residues were deleted from the C-terminus (containing nearly the entire alpha 4-helix), and infectious particles were still produced, although alpha 4-alpha 4' is supposedly vital for CP dimerization and nucleocapsid formation. We further analyzed two mutants (Delta C20-43 and Delta C64-96 viruses) with relatively large deletions that still replicated well in BHK-21 cells. Our data indicate that internal deletions within CP impaired viral replication or assembly, resulting in attenuated virus proliferation in cells and attenuated virulence in duck embryos, and these deletion mutations are quite stable in cell culture. An in vivo assay indicated that both Delta C20-43 virus and Delta C64-96 virus were highly attenuated in ducklings but still immunogenic. Single-dose immunization with Delta C20-43 virus or Delta C64-96 virus could protect ducklings from a lethal challenge with good antigen clearance. Together, our data shed light on replication/assembly defective TMUV with internal deletions in CP and provide an effective approach to attenuate viral virulence in live vaccines without changing the antigen composition.